Voriconazole product-specific bioequivalence guidance
Submitted by Anonymous (not verified) on 30 June 2025 - 9:51
Voriconazole product-specific bioequivalence guidance
Tadalafil product-specific bioequivalence guidance
Submitted by Anonymous (not verified) on 30 June 2025 - 9:35
Tadalafil product-specific bioequivalence guidance
Repaglinide product-specific bioequivalence guidance
Submitted by Anonymous (not verified) on 30 June 2025 - 9:25
Repaglinide product-specific bioequivalence guidance
Process for submitting existing data on medicinal products authorised for human use – SIAMED II & XEVMPD to PMS deltas - Chapter 9
Submitted by Anonymous (not verified) on 30 June 2025 - 9:14
Process for submitting existing data on medicinal products authorised for human use – SIAMED II & XEVMPD to PMS deltas - Chapter 9
Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan, emtricitabine,tenofovir disoproxil, Date of authorisation: 16/12/2016, Revision: 17, Status: Authorised
Submitted by Anonymous (not verified) on 30 June 2025 - 9:04
Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan, emtricitabine,tenofovir disoproxil, Date of authorisation: 16/12/2016, Revision: 17, Status: Authorised
Quarterly System Demo - Q2 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 June 2025, 09:00 (CEST) to 26 June 2025, 10:45 (CEST)
Submitted by Anonymous (not verified) on 30 June 2025 - 9:00
Quarterly System Demo - Q2 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 June 2025, 09:00 (CEST) to 26 June 2025, 10:45 (CEST)
List of signals discussed at PRAC since September 2012
Submitted by Anonymous (not verified) on 30 June 2025 - 8:51
List of signals discussed at PRAC since September 2012
PRAC recommendations on signals adopted at the 2-5 June 2025 PRAC meeting
Submitted by Anonymous (not verified) on 30 June 2025 - 8:47
PRAC recommendations on signals adopted at the 2-5 June 2025 PRAC meeting
Requesting scientific advice or protocol assistance from EMA
Submitted by Anonymous (not verified) on 30 June 2025 - 8:23
Requesting scientific advice or protocol assistance from EMA
Human medicines European public assessment report (EPAR): Vyjuvek, beremagene geperpavec, Date of authorisation: 23/04/2025, Revision: 1, Status: Authorised
Submitted by Anonymous (not verified) on 30 June 2025 - 7:27
Human medicines European public assessment report (EPAR): Vyjuvek, beremagene geperpavec, Date of authorisation: 23/04/2025, Revision: 1, Status: Authorised